Antileishmanial activity in Israeli plants

References

• Ali, H., Konig, G. M., Khalid, S. A., Wright, A. D. & Kaminsky, R. (2002). Evaluation of selected Sudanese medical plants for their in vitro activity against hemoflagellates, selected bacteria, HIV-1-RT and tyrosine kinase inhibitory, and for cytotoxocity. Journal of Ethnopharmcology, 83, 219-228.
   Google Scholar
• Amato, V. S., Tuon, F. F., Siqueira, A. M., Nicodemo, A. C. & Neto, V. A. (2007). Treatment of mucosal leishmaniasis in Latin America: systematic review. American Journal of Tropical Medicine and Hygiene, 77, 266–274.
   PubMed Web of Science ®Google Scholar
• Artis, D., Speirs, K., Joyce, K., Goldschmidt, M. H., Caamano, J., Hunter, C. A. & Scott, P. (2003). NF-kB1is required for optimal CD4+ Th 1 celldevelopment and resistance to Leishmania major. Journal of Immunology, 170, 1995–2003.
   PubMed Web of Science ®Google Scholar
• Bailey, C. & Danin, A. (1981). Bedouin plant utiliza-tion in Sinai and the Negev. Economic Botany, 35, 115-162.
   Google Scholar
• Borgers, M., Degreef, H. & Cauwenbergh, G. (2005). Fungal infections of the skin: infection process and antimycotic therapy. Current Drug Targets, 8, 849–862.
   Google Scholar
• Braga, F. G., Bouzada, M. L. M., Fabri, R. L., Matos, M. de O., Moreira, F. O., Scio, E. & Coimbra, E. S. (2007). Antileishmanial and anti-fungal activity of plants used in traditional medicine in Brazil. Journal of Ethnopharmacology, 11, 396-402.
   Google Scholar
• Chakrabandhu, K., Huault, S. & Hueber, A. O. (2008). Distinctive molecular signaling in triple-negative breast cancer cell death triggered by hexadecylpho-sphocholine (miltefosine). FEBS Letters, 582, 4176-4184.
   Google Scholar
• Chan-Bacab, M. J. & Pena-Rodriguez, L. M. (2001). Plant natural products with leishmanicidal activity. Natural Product Reports, 18, 674–688.
   PubMed Web of Science ®Google Scholar
• Cohen, H. A. & Wahaba, A. (1979). Treatment of leishmaniasis recidivans with intralesional injections of emetine HC1: a case report. Acta Dermato-Venereologica, 59, 549–552.
   PubMedGoogle Scholar
• Croft, S. L. & Coombs, G. H. (2003). Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs. Trends in Parasitology, 19, 502–508.
   PubMed Web of Science ®Google Scholar
• Das, L., Dana, N., Badyopadhyay, S. & Das, P. K. (2001). Successful therapy of lethal murine visceral leishmaniasis with cysteine involves up-regulation of nitric oxide and favorable T cell response. Journal of Immunology, 166, 4020–4028.
   PubMed Web of Science ®Google Scholar
• Desrivot, J., Waikedre, J., Cabalion, P., Herrenknecht, C., Bones, C., Hocquemiller, R. & Fournet, A. (2007). Antiparasitic activity of some New Caledonian medicinal plants. Journal of Ethnopharmacology, 112, 7–12.
   PubMed Web of Science ®Google Scholar
• El-On, J., Bazarsky, E. & Sneir, R (2007). Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod. Experimental Parasitology, 116, 156–162.
   PubMed Web of Science ®Google Scholar
• Engwerda, C. R, Murphy, M. L., Cotterell, S. E., Smelt, S. C. & Kaye, P. M. (1998). Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. European Journal of Immunology, 28, 669–680.
   PubMed Web of Science ®Google Scholar
• Friedman, J., Yaniv, Z., Dafni, A. & Pavlevitch, D. (1986). A preliminary classification of the healing potential of medicinal plants, based on rational analysis of an ethnopharmacological field survey among Beduins in the Negev desert, Israel. Journal of Ethnopharmcology, 16, 275-287.
   Google Scholar
• Golan-Goldhirsh, A., Sathiyamoorthy, P., Lugasi-Evgi, H., Kedar, I., Pollack, Y. & Gopas, J. (2000). Biotechnological potential of Israeli desert plant of the Negev. Acta Horticulturae, 523, 29–36.
   Google Scholar
• Griscavage, J. M., Wilk, S. & Ignaro, L. J. (1996). Inhibition of the proteosome pathway interferes with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-KB. Proceedings of the National Academy of Sciences of the United States of America, 93, 3308–3312.
   PubMed Web of Science ®Google Scholar
• Inge, L. D. & Wilson, J. W. (2008). Update on the treatment of tuberculosis. American Family Physician, 78,457-465.
   Google Scholar
• Iskander, I. O. (1978). Rifampicin in cutaneous leishmaniasis. Journal of International Medical Research, 6, 280-285.
   PubMed Web of Science ®Google Scholar
• Jha, T. K. (2006). Drug unresponsiveness and combi-nation therapy for kala-azar. Indian Journal of Medical Research, 123, 389–398.
   PubMed Web of Science ®Google Scholar
• Kayser, O., Kinderlen, A. F. & Croft, S. L. (2003). Natural product as antiparasitic drugs. Parasitology Research, 90 (Suppl. 2), S55-S62.
   Google Scholar
• Kirby, G. C. (1996). Medical plants and the control of protozoal disease, with particular reference to malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 605–609.
   PubMed Web of Science ®Google Scholar
• Lanternier, F. & Lortholary, O. (2008). Liposomal amphotericin B: what is its role in 2008? Clinical Microbiology and Infection, 4 (Suppl.), 71-83.
   Google Scholar
• Lirussi, D., Li, J., Prieto, J. M., Gennari, M., Buschiazzo, H., Rios, J. L. & Zaidenberg, A. (2004). Inhibition of Tgpanosoma cruzi by plant extracts used in Chinese medicine. Fitoterapia, 75, 718–723.
   PubMed Web of Science ®Google Scholar
• Lockman, Y., Vardy, D., Ohayon, D. & El-On, J. (1991). The failure of traditionally used desert plants to act against cutaneous leishmaniasis in experimen-tal animals. Annals of Tropical Medicine and Parasitology, 85, 14-17.
   Google Scholar
• May, M. J. & Gosh, S. (1998). Signal transduction through NF-KB. Immunology Today, 19, 80–88.
   PubMedGoogle Scholar
• Matsuda, H., Yoshida, K., Miyagawa, K., Nemoto, Y., Asao, Y. & Yoshikawa, M. (2006). Nuphar alkaloids with immediately apoptosis-inducing activity from Nuphar pumilum and their structural requirements for the activity. Bioorganic and Medicinal Chemistry Letters, 16, 1567–1573.
   PubMed Web of Science ®Google Scholar
• Mehta, R & Champney, W. S. (2003). Neomycin and paromomycin inhibit 30S ribosomal subunit assem-bly in Staphylococcus aureus. Current Microbiology, 47, 237–243.
   PubMed Web of Science ®Google Scholar
• Mise-Omata, S., Kuroda, E., Sugiura, T., Yamashita, U., Obata, Y. & Doi, T. S. (2009). The NF-kappaB RelA subunit confers resistance to Leishmania major by inducing nitric oxide synthase 2 and Fas expression but not Thl differentiation. Journal of Immunology, 182, 4910–4916.
   PubMed Web of Science ®Google Scholar
• Modzelewska, A., Sur, S., Kumar, S. K. &, Khan, S. R. (2005). Sesquiterpenes: natural products that decrease cancer growth. Current Medicinal Chemistry - Anti-Cancer Agents, 5,477-499.
   Google Scholar
• Mukbel, R. M., Patten, C., Gibson, K., Ghosh, M., Petersen, C. & Jones, D. E. (2007). Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide. American Journal of Tropical Medicine and Hygiene, 76, 669-675.
   Google Scholar
• Ndjakou Lenta, B. N., Vonthom-Senecheau, C., Soh, R. F., Tantangmo, F., Ngouela, S., Kaiser, M., Tsamo, E., Anton, R. & Weniger, B. (2007). In vitro antiprotozoal activities and cytotoxicity of some selected Cameroonian medical plants. Journal of Ethnopharmacology, 111, 8–12.
   PubMed Web of Science ®Google Scholar
• Okpekon, T., Yolou, S., Gleye, C., Roblot, F., Loiseau, P., Bones, C., Grellier, P., Frappier, F., Laurens, A. & Hocquemiller, R. (2004). Antiparasitic activities of medical plants used in Ivory Cost. Journal of Ethnopharmacology, 90, 91–97.
   PubMed Web of Science ®Google Scholar
• Orhan, I., Sener, B., Atici, T., Brun, R., Perozzo, R. & Tasdemir, D. (2006). Turkish freshwater and marine macrophyte extracts show in vitro antiprotozoal activity and inhibit FabI, a key enzyme of Plasmodium falciparum fatty acid biosynthesis. Phytomedicine, 13, 388–393.
   PubMed Web of Science ®Google Scholar
• Pavlevitch, D. & Yaniv, Z. (1991). Medical Plants of the Holy Land. Tel Aviv, Israel: Tammuz.
   Google Scholar
• Robert, M. T. M. (2006). Current understanding on the immunology of leishmaniasis and recent devel-opments in prevention and treatment. British Medical Bulletin, 75-76, 115-130.
   Google Scholar
• Rocha, L. G., Almeida, J. R. G. S., Macedo, R. O. & Barbosa-Filho, J. M. (2005). A review of natural products with antileishmanial activity. Phytomedicine, 12, 514–535.
   PubMed Web of Science ®Google Scholar
• Roehm, N. W., Rodgers, G. H., Hatfield, S. M. & Glasebrook, A. L. (1991). An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. Journal of Immunological Methods, 142, 257–265.
   PubMed Web of Science ®Google Scholar
• Santos, D. O., Coutinho, C. E., Madeira, M. F., Bottino, C. G., Vieira, R. T., Nascimento, S. B., Bernardino, A., Bourguignon, S. C., Corte-Real, S., Pinho, R. T., Rodrigues, C. R. & Castro, H. C. (2008). Leishmaniasis treatment — a challenge that remains: a review. Parasitology Research, 103, 1–10.
   PubMed Web of Science ®Google Scholar
• Sathiyamoorthy, P., Lugasi-Evgi, H., Shlesinger, P., Kedar, I., Gopas, J., Pollack, Y. & Golan-Goldhirsh, A. (1999). Screening for cytotoxic and anti-malarial activities in desert plants of the Negev and Bedouin market plant products. Pharmaceutical Biology, 37, 188–195.
   Web of Science ®Google Scholar
• Subeki, S., Matsuura, H., Takahashi, K., Nabeta, K., Yamasaki, M., Maede, Y. & Katakura, K. (2007). Screening of Indonesian medicinal plant extracts for antibabesial activity and isolation of new quassinoids from Brucea javanica. Journal of Natural Products, 70, 1654–1657.
   PubMed Web of Science ®Google Scholar
• Takahashi, M., Fuchino, H., Sekita, S. & Satake, M. (2004). In vitro leishmanicidal activity of some scarce natural products. Phytotherapy Research, 18, 573–578.
   PubMed Web of Science ®Google Scholar
• Ukil, A., Biswas, A., Das, T. & Das, P. K. (2005). 1813-Glycyrrhetinic acid triggers curative Thl response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-KB. Journal of Immunology, 175, 1161–1169.
   PubMed Web of Science ®Google Scholar
• Williams, C., Espinosa, O. A., Montenegro, H., Cubilla L., Capson, T. L., Ortega-Barria, E. & Romero, L. I. (2003). Hydrosoluble formazan XTT: its application to natural products drug discovery for Leishmania. Journal of Microbiological Methods, 55, 813–816.
   Google Scholar